Skip to content

A Retro/Prospective Multi-Centre Data Capture on REDAPT Sleeved Stem

A Retro/Prospective Multi-Centre Data Capture on REDAPT Sleeved Stem

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05600712
Enrollment
45
Registered
2022-10-31
Start date
2022-01-11
Completion date
2024-02-14
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Safety and Performance

Brief summary

Retro/Prospective study to collect 2 year follow-up on REDAPT sleeved stem.

Detailed description

The purpose of this study is to assess performance and safety of the Smith & Nephew REDAPT Sleeved Stem by collecting retrospective 2 year post-op with PROMs or prospective 2 year post-op with PROMs.

Interventions

DEVICEREDAPT Sleeved Stem

The REDAPT Sleeved Stem is designed to provide secondary proximal support to the distal fixation and enhance implant stability.

Sponsors

Smith & Nephew, Inc.
CollaboratorINDUSTRY
Foundation for Orthopaedic Research and Education
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants who have been implanted with REDAPT Sleeved Stem

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Primary and revision surgery for hip degenerative joint disease including osteoarthritis, avascular necrosis, and traumatic arthritis. * Rheumatoid arthritis, congenital dysplasia, femoral neck fracture, trochanteric fractures of the proximal femur with head involvement, and fracture-dislocation of the hip.

Exclusion criteria

* Conditions that would eliminate or tend to eliminate adequate implant support or prevent the use of an appropriate size implant (blood supply limitations, osteoporosis/metabolic disorders, infections) * Mental or neurological conditions impairing or precluding cooperation with post-operative protocols and proper response to PROMs. * Skeletal immaturity.

Design outcomes

Primary

MeasureTime frameDescription
Harris HIp Score (HHS)2 yearsmeasures pain, function, absence of deformity and range of motion after hip surgery. This is performed by a qualified health care provider. The higher the score, the better the outcome.
Hip Disablity and Osterarthritis Outcome Score (HOOS)2 yearScoring from 0-100 with 0 indicating the worst possible hip symptoms and 100 indicating no symptoms. This tool assesses patients opinion of their hip and associated problems, evaluate symptoms and functional limitations. There are 40 items assessing 5 subscales of: Pain, symptoms, activities of daily living (ADL), function in sport and recreation and Hip related quality of life.
HOOS Jr.2 yearScoring from 0-100 with 0 indicating the worst possible hip symptoms and 100 indicating no symptoms. This tool assesses patients opinion of their hip and associated problems, evaluate symptoms and functional limitations. this version is shortened to 6 questions assessing function, pain and quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026